Health Care Roundup: Market Talk

Online job listing company Careerbuilder + Monster files for bankruptcy

Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

Managing Crisis Communications: Edelman Smithfield Managing Director Ira Gorsky, Live at Nasdaq

TD Synnex Stock Surges on Stronger-Than-Expected Q2 Results